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Abstract: One of the present challenges in optical coherence tomography 
(OCT) is the visualization of deeper structural morphology in biological 
tissues. Owing to a reduced scattering, a larger imaging depth can be 
achieved by using longer wavelengths. In this work, we analyze the OCT 
imaging depth at wavelengths around 1300 nm and 1600 nm by comparing 
the scattering coefficient and OCT imaging depth for a range of Intralipid 
concentrations at constant water content. We observe an enhanced OCT 
imaging depth for 1600 nm compared to 1300 nm for Intralipid 
concentrations larger than 4 vol.%. For higher Intralipid concentrations, the 
imaging depth enhancement reaches 30%. The ratio of scattering 
coefficients at the two wavelengths is constant over a large range of 
scattering coefficients and corresponds to a scattering power of 2.8 ± 0.1. 
Based on our results we expect for biological tissues an increase of the OCT 
imaging depth at 1600 nm compared to 1300 nm for samples with high 
scattering power and low water content. 
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1. Introduction 
Optical coherence tomography (OCT) is a high resolution, non-invasive, coherence-gated 
imaging technique with a wide range of applications in medicine [1–5]. One of the present 
challenges in OCT is the visualization of deeper structural morphology in biological tissues, 
which can improve existing and create new applications. For current OCT systems the 
imaging depth is approximately 1–2 mm. The large scattering coefficient of biological tissues 
limits the amount of light that can be collected from structures located deep in the tissue. 
Since the optical properties of biological tissues vary significantly with wavelength, the 
imaging depth can be improved by using a light source with an optimal imaging wavelength. 
The general trend for the scattering coefficient is to decrease with increasing wavelength. 
Therefore, a longer wavelength is potentially more advantageous for deeper imaging. The first 
OCT system operated in the 800 nm spectral range. The longer wavelength OCT systems, 
operating in the 1050 nm and 1300 nm spectral bands, were introduced soon after and an 
improved imaging depth was demonstrated [6–10]. However, the use of longer wavelengths 
for imaging depth improvement is restricted by the increased optical absorption of water [11]. 
Nevertheless, the spectral window from 1600 to 1800 nm, between two primary water 
absorption bands (1400 to 1500 nm and 1900 to 2200 nm), is recognized as a promising 
choice to further increase the OCT imaging depth. OCT in this part of the spectrum was 
demonstrated [12–14], and a direct comparison of OCT systems operating at 810, 1330, and 
1570 nm was presented [15]. Also, a comparison of light penetration depth for different OCT 
light sources in skin dermis, liver, and gallbladder was reported [16]. Although these studies 
have shown that the use of longer wavelengths enables an enhanced imaging depth for certain 
types of biological tissues, the advantage of using the 1600 – 1800 nm spectral band remains 
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to be quantified. Since the different OCT wavelengths were compared based on images that 
were obtained with different OCT setups, the measured imaging depth depended not only on 
tissue properties, but also on the technical characteristics of the used OCT systems. In this 
study, we perform a quantitative comparison of the OCT imaging depth at 1300 nm and 1600 
nm wavelengths using a single time-domain OCT set-up of which the technical performance 
at the two wavelengths is matched. Using Intralipid with a constant absorption coefficient as 
tissue phantom material, we determine the influence of the scattering on the OCT imaging 
depth. 
2. Materials and methods 
2.1 Time-domain optical coherence tomography 
The OCT experiments are conducted with a home-built time-domain OCT system. A 
schematic of the set-up is depicted in Fig. 1(a). Light from a supercontinuum light source 
(Fianium SC 450-4) is coupled into a single-mode fiber (1550 BHP, Thorlabs) and collimated 
(FiberPort system, PAF-X-18-PC-C, focal length 18.4 mm, Thorlabs) at the input of a 50/50 
Michelson interferometer. In the sample and reference arms, identical achromatic lenses with 
focal length 45 mm are used to focus the light on the sample and reference mirrors, 
respectively. Depth scanning is performed by moving the reference arm mirror (at a velocity V 
= 20 mm/sec), which is mounted together with the lens on a translator (Physik Instrumente M 
664.164). In the sample arm, the beam is focused at the front glass-Intralipid interface of the 1 
mm thick cuvette. We have fixed focus configuration, i.e the focus position doesn’t change 
during A-scan. The angle between the probe beam and the cuvette is ~70° to avoid specularly 
reflected light in the signal. Light returning from reference and sample arms is combined and 
coupled into a single-mode fiber. The interferometric signal is detected with a photodiode 
(New focus, model 2011), band-pass filtered and demodulated by a lock-in 
 
Fig. 1. (a) Overview of the time domain OCT set-up used in the experiments: BS – 
beamsplitter; C1,C2 - fiber collimating ports; L1, L2 - reference and sample arm lenses; M - 
reference mirror; SMF - single mode fibers; F - long pass filter; PD - photodetector; Lock-in – 
Lock-in amplifier; PC - personal computer; Fianium – supercontinuum light source; (b) OCT 
input spectra for the two wavelength bands; (c) coherence function at the two OCT 
wavelengths (measured with an OD3 filter in sample arm). 
amplifier set to the Doppler frequency f = 2V/λ0. To reduce noise, the signal is averaged over 
100 A-scans. The sample is not scanned in the lateral direction. The central wavelength λ0 and 
the bandwidth of the light coupled into the interferometer is changed between 1300 and 1600 
nm bands using long pass filters (Thorlabs, FEL1250 and FEL1500, respectively) and by 
adjusting the bandwidth of the light coupled to the fiber using the effect of chromatic 
aberrations [Fig. 1(a)]. 
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2.2 Performance matched OCT at 1300 nm and 1600 nm 
The OCT signal magnitude id(z) as a function of depth z is proportional to the square root of 
the power backscattered from depth z. In the single backscattering approximation and with a 
coherence length lc less than the photon mean free path 1/µt [17], with µt the attenuation 
coefficient, id(z) ~P(z)1/2 = [P0 K µb h(z) exp(–2µtz)]1/2 where P0 is the incident power on the 
sample; the parameter K is proportional to the coherence length lc; µb is the backscattering 
coefficient and h(z) is the confocal point spread function (PSF). In the following, we assume 
either dynamic focusing, or that the data is corrected for the point spread function [18]. The 
factor of 2 in the exponent accounts for the round-trip attenuation to and from the depth z; the 
square root accounts for the fact that the OCT signal magnitude is proportional to the 
amplitude of the field returning from the sample, rather than power. 
The OCT signal-to-noise ratio is defined as SNR = 10log10(P0/Pnoise), where Pnoise is the 
noise power level. We define the imaging depth Zimage as the depth at which P(z) = Pnoise, or: 
 ( )1 [ 10]
2 10image bt
SNRZ Ln K Lnµ
µ
= +   (1) 
Equation (1) shows that the OCT imaging depth is determined by the optical properties of 
the sample as well as by the characteristics of the OCT setup itself. For a quantitative 
comparison of the imaging depth at different center wavelengths only in terms of the optical 
properties of the sample, it is important to take into account the system characteristics at the 
two wavelengths. 
Firstly the spectral bandwidth of the light coupled into the interferometer [Fig. 1(b)] is 
adjusted to reach equal coherence lengths of lc = 10 µm at both OCT wavelengths [Fig. 1(c)]. 
Secondly, the effect of the confocal point spread function on the OCT signal at the two 
imaging wavelengths is taken into account following the procedure outlined in our previous 
work [18]. In brief, the change of the OCT signal as a function of distance between the probed 
location z in the tissue and the focus position z0 is corrected using the axial PSF, which, in the 
case of diffuse reflection, has the form: h(z) = 1/ {[(z-z0)/(2ZR)]2 + 1}, where ZR is the 
Rayleigh length in air. The measured Rayleigh lengths (half the depth of focus) are 0.29 and 
0.25 mm at 1300 and 1600 nm, respectively. Due to the achromaticity of the lens, the focus 
position is different for the two wavelength bands. The positions of the sample arm and 
reference arm lens are shifted 500 µm when changing from 1300 nm to 1600 nm to 
compensate for this. 
Thirdly, the SNR for a shot-noise limited time-domain OCT system is calculated from the 
mean square detector current <id2> and the noise variance σn2 as: 
 
2
210 10
d s
n
i P
SNR Log Log
E fν
η
σ
 
= =  
∆ 
  (2) 
where η is the quantum efficiency of the detector, Ps is the power returning from the sample 
arm; Ev is the photon energy and ∆f is the electronic detection bandwidth. The ratio Ps/Ev in 
Eq. (2) equals the number of photons returning from the sample arm per second. Therefore, 
the input power is adjusted to obtain an equal amount of photons detected from the sample 
arm with a mirror positioned at the focus The resulting input powers are 4.5 mW and 6.4 mW 
for 1300 nm and 1600 nm, respectively, and the power of the light coupled to the detector 
from the sample arm are 0.33 mW and 0.27 mW, respectively (the optical components have 
different efficiencies at 1300 and 1600 nm). Since the photon energy at 1300 nm is higher 
than at 1600 nm, the number of detected photons returning from the sample arm is equal for 
both OCT wavelengths. Because the quantum efficiency of the photodetector is equal at the 
two OCT wavelengths, the same signal is measured for the two OCT wavelengths. Although 
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our OCT system is not shot-noise limited, the use of the same light source and photodetector 
ensures that the noise at both wavelengths is matched and an equal SNR is achieved. 
Finally, the reference arm power is adjusted using a neutral density filter to optimize the 
SNR. The lock-in amplifier demodulation frequencies f = 2V/λ0 are 30.5 and 25 kHz for 1300 
and 1600 nm, respectively, but the detection bandwidth ∆f is equal. As a result of the 
procedure outlined here, the SNR for an OCT measurement with a mirror in the sample arm is 
equal at the two OCT wavelengths, which we measured to be 90 dB at 1300 and 1600 nm [see 
Fig. 1(c)]. 
2.3 Phantom preparation 
As a scattering medium we use dilutions of a single batch of 22.7 vol.% (20 weight %) 
Intralipid (Fresenius-Kabi). Our choice is determined by the fact that Intralipid is a common 
tissue phantom for optical measurements and it allows us to achieve a high concentration of 
scatterers. For our measurements Intralipid is diluted to lower concentrations by a mixture of 
deionized water and heavy water (D2O). Heavy water has an absorption spectrum similar to 
water, but the absorption bands are shifted to longer wavelengths [19]. Consequently, heavy 
water has negligible absorption for wavelengths lower than 1700 nm, which we 
experimentally verified. The refractive index of D2O is only slightly different from that of 
normal water [20], therefore we assume that dilution by heavy water has no significant 
influence on the scattering properties of Intralipid. The ratio of heavy water and water is such 
that for all samples the total water concentration (77 vol.%) and, consequently, the absorption 
is constant, and only the scattering properties vary. We prepared the following samples: 
0.7, 1.4, 2.8, 5.7, 8.5, 11.4, 14.2, 17.0, 19.9 and 22.7 volume % Intralipid. 
2.4 Determination of optical parameters and imaging depth 
OCT measurements at each Intralipid concentration are performed 3 times. For each 
measurement, 100 A-scans are averaged. Noise background and noise standard deviation are 
determined from the part of the OCT signal (190 µm) within the first glass wall. After 
background subtraction, the OCT signal is corrected for the confocal point spread function 
(dividing the OCT signal by the PSF) [18]. The OCT attenuation coefficient is determined 
from a single exponential fit of the noise corrected OCT signal in depth: id(z) = a exp(-µtz) 
with a and µt the two free running parameters. The influence of multiple scattering effects is 
minimized by using only the first 190 µm of the OCT signal for fitting. The OCT imaging 
depth is calculated from the fit by extending the fitted curve to the point where it intercepts 
the noise floor (defined as the noise mean plus one standard deviation). 
The scattering coefficient of our samples is determined from the measured attenuation 
coefficient by subtracting the water absorption coefficient from the fitted attenuation 
coefficient. The variation of the absorption coefficient over the wavelengths of the input 
spectra is taken into account by calculating the water absorption integrated over the input 
spectra. We obtain µa = 0.2 mm−1 and µa = 1.1 mm−1 for 1300 nm and 1600 nm spectra, 
respectively. Finally, the standard deviation is calculated from the three subsequent 
measurements. 
3. Results 
3.1 OCT signal attenuation 
Figure 2 shows averaged OCT A-scans at three different Intralipid concentrations. The OCT 
signal magnitude at the first glass/Intralipid interface increases with concentration as is 
expected from the increasing backscattering with increasing particle concentration. The signal 
magnitudes for 1300 and 1600 nm are approximately equal, which shows that the 
backscattering coefficient is similar for both cases (the same amount of photons is detected). 
For the 0.7 vol.% Intralipid concentration, the OCT signal attenuation with depth is lower at 
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1300 nm compared to 1600 nm; for the 8.5 vol.% and 22.7 vol.% concentrations the 
attenuation coefficient is higher at 1300 nm compared to 1600 nm. 
 
Fig. 2. OCT signals vs. depth for 0.7%, 8.5% and 22.7 vol.% Intralipid samples for the two 
wavelengths (data before background subtraction and PSF correction). 
Figure 3 shows the measured attenuation and resulting scattering coefficient for all 
Intralipid concentrations. For low Intralipid concentrations the attenuation coefficient is 
higher at 1600 nm compared to 1300 nm. At Intralipid concentrations larger than ~4 vol.% the 
attenuation coefficient at 1300 nm exceeds that of 1600 nm. As expected, the scattering 
coefficient is higher at 1300 nm for all measured Intralipid concentrations. Note that variation 
of the scattering coefficient with Intralipid concentration shows a clear deviation from the 
linear dependence expected for low-density media: for high Intralipid concentrations we see a 
non-linear dependence of the scattering coefficient, which is attributed to concentration 
dependent scattering [21–23]. 
 
Fig. 3. Measured OCT attenuation (a) and scattering (b) coefficients versus Intralipid 
concentration. The solid lines are visual guides. Error bars depict standard deviations of the 
measurements. 
3.2 OCT imaging depth comparison 
Figure 4 shows the OCT imaging depth for the two OCT wavelengths. At 1300 nm, the 
imaging depth is larger for low Intralipid concentrations. For example, for the lowest 
Intralipid concentration (0.7 vol.%) the imaging depth is approximately 3 mm larger for 1300 
nm compared to 1600 nm. For 4 vol.% Intralipid the imaging depth at 1600 nm is equal to that 
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at 1300 nm. For higher Intralipid concentrations the imaging depth at 1600 nm is larger. At 
the maximum Intralipid concentration (22.7 vol.%) the OCT imaging depth is 30% larger for 
1600 nm compared to 1300 nm (0.8 mm vs 0.6 mm, respectively). In the limit of high 
Intralipid concentrations the effect of the water absorption on the total attenuation is small at 
both wavelengths. Consequently, the imaging depth is dominated by the difference in 
scattering at the two OCT wavelengths. 
 
Fig. 4. OCT imaging depth for varying Intralipid concentration measured at 1300 and 1600 nm. 
The solid lines are visual guides. Error bars depict standard deviations of the measurements. 
Inset: ratio of measured OCT imaging depths. The dashed line indicates equal imaging depth at 
1300 and 1600 nm. 
The inset of Fig. 4 shows the ratio of the OCT imaging depth at 1600 nm to that at 1300 
nm. For high Intralipid concentrations the imaging depth is dominated by scattering, the ratio 
of imaging depths is larger than unity. In this limit the 1600 nm OCT wavelength has an 
approximately 30% larger imaging depth. For low Intralipid concentration, the OCT imaging 
depth is dominated by absorption, the ratio of imaging depths is smaller than unity and 1300 
nm has a larger imaging depth. 
It is also interesting to note the dissimilarity of the dependence of the imaging depth at 
1300 and 1600 nm on the Intralipid concentration. At 1300 nm it monotonically increases 
with decreasing Intralipid concentration. The imaging depth at 1600 nm has the same trend, 
except for low concentrations, where it starts to decrease. This difference can be explained by 
the stronger contribution of water absorption to the total attenuation coefficient at 1600 nm 
compared to 1300 nm: for very low Intralipid concentrations the scattering coefficient 
decreases, resulting in a decreasing backscattering, which lowers the OCT signal amplitude 
and the remaining high absorption lead to decrease of imaging depth. A similar effect is 
expected at 1300 nm, but only for very low Intralipid concentrations, not within our 
measurement range. 
4. Discussion 
Since the technical characteristics of the OCT setups at 1300 and 1600 nm imaging 
wavelengths are matched, only the optical properties of the sample determine the difference in 
the measured OCT imaging depth. In the determination of the OCT imaging depth, two 
sample parameters are of importance: the backscatter coefficient µb, which determines the 
initial magnitude of the OCT signal, and the attenuation coefficient µt, which determines how 
fast the OCT signal decays with depth to the noise floor. 
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The backscatter coefficient µb is formally defined as the (total) scattering coefficient of an 
isotropically scattering particle with a phase function pISO(θ) = p(180), where p(180) is the 
phase function of the original scatterer in the backward direction. This leads to 
µb = 4πµs p(180). In the OCT geometry the following interpretation of µb is more appropriate: 
µb = µs × ∫NAp(θ)2πsinθdθ, e.g. the phase function integrated over the numerical aperture (NA) 
of the OCT sample arm lens in the backscatter direction. From Eq. (1), the magnitude of the 
OCT signal immediately after the front glass-Intralipid boundary (z = 0) is therefore 
proportional to the square root of the scattering coefficient µs. Figure 2 shows that the OCT 
magnitude increases with Intralipid concentration, consistent with the observed increase in the 
scattering coefficient. In addition, the magnitudes of the OCT signal at 1300 and 1600 nm for 
the same Intralipid concentration are similar. This suggests that the difference in 
backscattering coefficient at these wavelengths is small. Since µs is larger at 1300 nm 
compared to 1600 nm [Fig. 3(b)], we conclude that the Intralipid scattering phase function in 
the backscattering direction (180°) within the detection NA is higher at 1600 nm compared to 
1300 nm. This observation is consistent with a reduced size parameter at 1600 nm compared 
to 1300 nm making the phase function more isotropic at 1600 nm compared to 1300 nm. 
Our measurements are performed on samples with constant H2O content. The reported 
scattering coefficients are calculated by subtracting a constant absorption from the measured 
attenuation coefficients [Fig. 3(a)]. Using this method we obtain a µs that approaches zero 
when no scattering is present [zero Intralipid concentration; see Fig. 3(b)]. In addition, the 
value of the scattering coefficient µs at 1300 nm is in good agreement to those found in 
Ref. [23]. For all Intralipid concentrations the scattering at 1600 nm is lower compared to 
1300 nm. However, since the absorption is higher at 1600 nm, the OCT imaging depth is 
enhanced compared to 1300 nm only for Intralipid concentrations above 4 vol.%. For 
Intralipid concentrations lower than 4 vol.% the lower scattering coefficient at 1600 is 
compensated by the higher absorption, resulting in an increased imaging depth for 1300 nm. 
In the limit of very high Intralipid concentrations the H2O absorption coefficient can be 
neglected and the difference between the scattering coefficients at the two wavelengths 
saturates at ∆µs~2.1 mm−1. Consequently, the OCT imaging depth enhancement also reaches a 
plateau at a difference of 200 µm, i.e. 30% higher for 1600 nm compared to 1300 nm. 
Recent work on the comparison of the performance of OCT systems with light sources 
centered at 1300 and 1650 nm [14] showed that the ratio of the attenuation coefficients for 10 
wt.% Intralipid at 1300 nm to 1650 nm is 1.24. This value is close to our result for this 
Intralipid concentration, which is 1.29 (with a minor difference in water absorption and 
central wavelength). However, because of the differences in setup characteristics and the fact 
that in the published work the attenuation coefficient was calculated without correction for the 
refractive index of Intralipid, it is difficult to compare our imaging depth measurements with 
these published results. 
It is interesting to compare the scattering coefficient of Intralipid at 1300 and 1600 nm. 
For a polydisperse solution of particles, like Intralipid, and the absence of strong absorption, 
the wavelength dependency of the scattering coefficient is described empirically in the form 
of a power law: µs = aλ-SP, where a and SP are the parameters for scattering amplitude and 
scattering power, respectively [24]. The parameter a is associated with the magnitude of the 
scattering, but does not depend on wavelength: tissues with high scattering coefficient µs have 
high a parameter and vice versa. The SP parameter determines how strong the scattering 
changes with wavelength. The value of SP is related to the average size of the scatterers: for 
particles with diameter d much smaller than wavelength of light (d<<λ) the parameter SP 
approaches 4 (Rayleigh scattering regime). With increasing particles size, the SP decreases 
(Mie scattering). From this simple model, changes in the scattering coefficient with 
wavelength (λ1<λ2) can be described as follows: 
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Figure 5 shows the measured scattering coefficient at 1600 nm versus that at 1300 nm for 
all Intralipid concentrations. From a linear fit to the data points using Eq. (3) we find 
SP = 2.8 ± 0.1, which is close to a previously reported value of SP for Intralipid SP = 2.4 
[24,25]. In addition, Fig. 5 shows that the relative difference in the scattering coefficient at 
1300 to 1600 nm remains approximately constant for all Intralipid concentrations. We can 
conclude that concentration dependent scattering effects are similar for the two wavelengths. 
Since the SP parameter describes the wavelength dependence of the scattering coefficient, 
this parameter can be used to predict changes in the OCT imaging depth with wavelength for 
biological tissues. From Eq. (3) follows that for samples with a low SP the variation in 
scattering with wavelength is small. In this case, the increase of the OCT imaging depth with 
increasing wavelength is expected to be small. For samples with a high SP the scattering 
coefficient shows a strong variation with wavelength and a relatively large increase of the 
OCT imaging depth can be expected. Additionally, for samples with significant water content, 
the higher water absorption in the 1600 – 1800 nm spectral band is a counteracting factor. 
Therefore, we expect an increase of the OCT imaging depth for samples with high SP and low 
water content (e.g. enamel) and we do not expect an increase of the OCT imaging depth for 
samples with a low SP and high water content (e.g. skin). However, since the wavelength 
dependence of the backscattering coefficient is not known a priori, the procedures, as outlined 
in this paper, should be followed to determine the optimum OCT imaging wavelength. 
 
Fig. 5. Measured µ s at 1600 nm versus 1300 nm. Sample points are marked according to the 
Intralipid concentration. From a linear fit to the data (solid line) we determine the SP value for 
Intralipid (indicated). The dashed lines indicate the 95% confidence interval of the fit. 
5. Conclusions 
We present a quantitative comparison of the OCT imaging depth in Intralipid (with constant 
water content of 77 vol.%) at 1300 and 1600 nm. For Intralipid concentrations larger than 4 
vol.% the imaging depth at 1600 nm becomes larger than for 1300 nm. We show that for high 
Intralipid concentrations the use of 1600 nm light gives a 30% larger OCT imaging depth 
compared to 1300 nm. Despite concentration dependent scattering effects, the ratio of 
scattering coefficients at the two wavelengths is constant. Additionally, we observe that 
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difference in the backscattering at these wavelengths is small, which suggests that the 
backscattering phase function at 1600 nm is higher than at 1300 nm. Regarding application to 
biological tissues, an increase of the OCT imaging depth at 1600 nm for samples with a high 
scattering power parameter and low water content is expected. 
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